Patent · US Active

Extended release biodegradable ocular implants

US10874605B2 · kind B2 · utility

5Cited by

28References

17Claims

0Family size

Assignee

Allergan, Inc. · US

Inventors

Thierry Nivaggioli · San Francisco, US
James Jane-Guo Shiah · Irvine, US
Qing Lin · San Diego, US

Key dates

Filing date	Dec 17, 2018
Grant date	Dec 29, 2020
Priority date	—
Expiry date	Dec 17, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/204
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.